Quantification of cell-free DNA in normal and complicated pregnancies: Overcoming biological and technical issues

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Manokhina, Irina ^a,b   Singh, Tanjot K ^a,b   Peñaherrera, Maria S ^a,b   Robinson, Wendy P ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG; ACTIN; AUTOANTIGEN; RASSF1 PROTEIN, HUMAN; RIBONUCLEASE P; RPP30 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL DROPLET POLYMERASE CHAIN REACTION; DNA DETERMINATION; DNA EXTRACTION; FALSE NEGATIVE RESULT; FEMALE; GESTATIONAL AGE; HUMAN; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; MATERNAL SERUM; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; PLACENTA; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; PREGNANCY; PREGNANCY COMPLICATION; REAL TIME POLYMERASE CHAIN REACTION; BLOOD; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; TROPHOBLAST;

ACTINS; AUTOANTIGENS; DNA; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEASE P; TROPHOBLASTS; TUMOR SUPPRESSOR PROTEINS;

EID: 84903767765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101500     Document Type: Article

References (44)

1. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775. (Pubitemid 28194317)
2. Ziegler A, Zangemeister-Wittke U, Stahel RA (2002) Circulating DNA: A new diagnostic gold mine? Cancer Treat Rev 28: 255-271. (Pubitemid 35439439)
3. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, et al. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487. (Pubitemid 27343304)
4. Bianchi DW (2004) Circulating fetal DNA: Its origin and diagnostic potential-a review. Placenta 25 Suppl A: S93-S101.
5. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105: 16266-16271.
6. Lun FM, Tsui NB, Chan KC, Leung TY, Lau TK, et al. (2008) Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A 105: 19920-19925.
7. Hill M, Finning K, Martin P, Hogg J, Meaney C, et al. (2011) Non-invasive prenatal determination of fetal sex: Translating research into clinical practice. Clin Genet 80: 68-75.
8. Hyland CA, Gardener GJ, Davies H, Ahvenainen M, Flower RL, et al. (2009) Evaluation of non-invasive prenatal RHD genotyping of the fetus. Med J Aust 191: 21-25.
9. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, et al. (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45: 184-188. (Pubitemid 29079115)
10. Caramelli E, Rizzo N, Concu M, Simonazzi G, Carinci P, et al. (2003) Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery doppler waveform and intrauterine growth restriction-a pilot study. Prenat Diagn 23: 367-371. (Pubitemid 36596963)
11. Farina A, LeShane ES, Romero R, Gomez R, Chaiworapongsa T, et al. (2005) High levels of fetal cell-free DNA in maternal serum: A risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 193: 421-425. (Pubitemid 41159536)
12. Vora NL, Johnson KL, Basu S, Catalano PM, Hauguel-De Mouzon S, et al. (2012) A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI. Prenat Diagn 32: 912-914.
13. Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, et al. (2004) Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 190: 707-713. (Pubitemid 38406782)
14. Hidestrand M, Stokowski R, Song K, Oliphant A, Deavers J, et al. (2012) Influence of temperature during transportation on cell-free DNA analysis. Fetal Diagn Ther 31: 122-128.
15. Jung M, Klotzek S, Lewandowski M, Fleischhacker M, Jung K (2003) Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 49: 1028-1029. (Pubitemid 36623507)
16. Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, et al. (2011) Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days. Prenat Diagn 31: 1300-1304.
17. Chiu RW, Poon LL, Lau TK, Leung TN, Wong EM, et al. (2001) Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 47: 1607-1613. (Pubitemid 32781573)
18. Repisk G, Sedlckov T, Szemes T, Celec P, Minrik G (2013) Selection of the optimal manual method of cell free fetal DNA isolation from maternal plasma. Clinical Chemistry and Laboratory Medicine 51: 1185-1189.
19. Tynan JA, Mahboubi P, Cagasan LL, van den Boom D, Ehrich M, et al. (2011) Restriction Enzyme-Mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma. The Journal of Molecular Diagnostics 13: 382-389.
20. Holmberg RC, Gindlesperger A, Stokes T, Lopez D, Hyman L, et al. (2013) Akonni TruTip((R)) and qiagen((R)) methods for extraction of fetal circulating DNA-evaluation by real-time and digital PCR. PLoS One 8: e73068.
21. Hromadnikova I, Zejskova L, Kotlabova K, Jancuskova T, Doucha J, et al. (2010) Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences-evaluation of diagnostic possibilities for predicting placental insufficiency. DNA Cell Biol 29: 295-301.
22. White HE, Dent CL, Hall VJ, Crolla JA, Chitty LS (2012) Evaluation of a novel assay for detection of the fetal marker RASSF1A: Facilitating improved diagnostic reliability of noninvasive prenatal diagnosis. PloS one 7: e45073.
23. Jin S, Lin XM, Law H, Kwek KY, Yeo GS, et al. (2012) Further improvement in quantifying male fetal DNA in maternal plasma. Clin Chem 58: 465-468.
24. Papantoniou N, Bagiokos V, Agiannitopoulos K, Kolialexi A, Destouni A, et al. (2013) RASSF1A in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn: 1-6.
25. Lim JH, Kim MH, Han YJ, Lee da E, Park SY, et al. (2013) Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidy. PLoS One 8: e56787.
26. Jakobsen TR, Clausen FB, Rode L, Dziegiel MH, Tabor A (2012) High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery. Prenat Diagn 32: 840-845.
27. Yu H, Shen Y, Ge Q, He Y, Qiao D, et al. (2013) Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia. Int J Mol Sci 14: 7571-7582.
28. Zeybek YG, Gunel T, Benian A, Aydinli K, Kaleli S (2013) Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies. J Obstet Gynaecol Res 39: 632-640.
29. Stein W, Muller S, Gutensohn K, Emons G, Legler T (2013) Cell-free fetal DNA and adverse outcome in low risk pregnancies. Eur J Obstet Gynecol Reprod Biol 166: 10-13.
30. Ashoor G, Poon L, Syngelaki A, Mosimann B, Nicolaides KH (2012) Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: Effect of maternal and fetal factors. Fetal Diagn Ther 31: 237-243.
31. Wang E, Batey A, Struble C, Musci T, Song K, et al. (2013) Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn: 1-5.
32. Farina A, Sekizawa A, Rizzo N, Concu M, Banzola I, et al. (2004) Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. Prenat Diagn 24: 293-297. (Pubitemid 38480665)
33. Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, et al. (2007) Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 170: 941-950. (Pubitemid 47339363)
34. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, et al. (2006) Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52: 2211-2218. (Pubitemid 44924994)
35. Tsui NB, Jiang P, Chow KC, Su X, Leung TY, et al. (2012) High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing. PLoS One 7: e48319.
36. Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci U S A 96: 9236-9241. (Pubitemid 29374738)
37. Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, et al. (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83: 8604-8610.
38. Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8: 135-160. (Pubitemid 29425900)
39. Henrich TJ, Gallien S, Li JZ, Pereyra F, Kuritzkes DR (2012) Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR. J Virol Methods 186: 68-72.
40. Zejskova L, Jancuskova T, Kotlabova K, Doucha J, Hromadnikova I (2010) Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma-Next step toward reliable non-invasive prenatal diagnostics. Exp Mol Pathol 89: 241-247.
41. Bartha JL, Finning K, Soothill PW (2003) Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol 101: 1135-1136. (Pubitemid 36566404)
42. Kolialexi A, Tounta G, Apostolou P, Vrettou C, Papantoniou N, et al. (2012) Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR. Eur J Obstet Gynecol Reprod Biol 161: 34-37.
43. Fernando MR, Chen K, Norton S, Krzyzanowski G, Bourne D, et al. (2010) A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage. Prenat Diagn 30: 418-424.
44. Wong D, Moturi S, Ankachatchai V, Mueller R, DeSantis G, et al. (2013) Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal diagnostic testing. Clin Biochem.